News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medivation, Inc. (MDVN) Announces Second Quarter 2014 Financial Results Teleconference On August 7, 2014



7/25/2014 9:27:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, CA--(Marketwired - July 24, 2014) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss second quarter 2014 financial results and provide a general business update on August 7, 2014 at 4:30 p.m. Eastern Time. A press release for the second quarter of 2014 will be released after markets close on August 7, 2014.

Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.


Contacts:

Rick Bierly
Chief Financial Officer
(415) 543-3470

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES